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Abstract
Background: Oxidative stress-mediated hepatotoxic effect of arsenic (As) is mainly due to the depletion of glutathione
(GSH) in liver. Taurine, on the other hand, enhances intracellular production of GSH. Little is known about the mechanism of
the beneficial role of taurine in As-induced hepatic pathophysiology. Therefore, in the present study we investigated its
beneficial role in As-induced hepatic cell death via mitochondria-mediated pathway.
Methodology/Principal Findings: Rats were exposed to NaAsO2 (2 mg/kg body weight for 6 months) and the hepatic
tissue was used for oxidative stress measurements. In addition, the pathophysiologic effect of NaAsO2 (10 mM) on
hepatocytes was evaluated by determining cell viability, mitochondrial membrane potential and ROS generation. As caused
mitochondrial injury by increased oxidative stress and reciprocal regulation of Bcl-2, Bcl-xL/Bad, Bax, Bim in association with
increased level of Apaf-1, activation of caspase 9/3, cleavage of PARP protein and ultimately led to apoptotic cell death. In
addition, As markedly increased JNK and p38 phosphorylation with minimal disturbance of ERK. Pre-exposure of
hepatocytes to a JNK inhibitor SP600125 prevented As-induced caspase-3 activation, ROS production and loss in cell
viability. Pre-exposure of hepatocytes to a p38 inhibitor SB2035, on the other hand, had practically no effect on these
events. Besides, As activated PKCd and pre-treatment of hepatocytes with its inhibitor, rottlerin, suppressed the activation of
JNK indicating that PKCd is involved in As-induced JNK activation and mitochondrial dependent apoptosis. Oral
administration of taurine (50 mg/kg body weight for 2 weeks) both pre and post to NaAsO2 exposure or incubation of the
hepatocytes with taurine (25 mM) were found to be effective in counteracting As-induced oxidative stress and apoptosis.
Conclusions/Significance: Results indicate that taurine treatment improved As-induced hepatic damages by inhibiting
PKCd-JNK signalling pathways. Therefore taurine supplementation could provide a new approach for the reduction of
hepatic complication due to arsenic poisoning.
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Introduction
Arsenic (As) is a widespread environmental toxin. It enters the
organisms by dermal contact, inhalation, or ingestion of
contaminated drinking water and affects nearly entire organ
systems of the body [1]. Investigations at the cellular and
molecular levels reveal that As enhances production of reactive
oxygen species (like, superoxide and hydrogen peroxide), causes
lipid peroxidation, enhances oxidation of proteins, enzymes as well
as DNA [2,3], disrupts mitosis and promotes apoptosis [4]. Among
several mechanisms, oxidative stress due to accelerated production
of free radicals has also been implicated for As-induced injury in
liver, kidney, brain, testes and other tissues [5,6].
Antioxidants have been found beneficial to mitigate chemical-
induced oxidative damage [7,8,9,10]. Antioxidant property of the
conditional amino acid, taurine (2-aminoethanesulfonic acid), is
also well-established and therefore, could be considered as a potent
candidate in this regard. Taurine is an end product of L-cysteine
metabolism and is the most abundant free amino acid in many
tissues. It protects many of the body’s organs against toxicity
and oxidative stress caused by various toxic substances
[11,12,13,14,15,16,17]. Taurine causes enhancement in intracel-
lular glutathione (GSH) levels by directing cysteine into the GSH
synthesis pathways as cysteine is a precursor of both taurine and
GSH [18,19]. Taurine also stabilizes GSH-metabolizing enzymes
[20], stimulates glucose-6-phosphate dehydrogenase that generates
NADPH needed for the restoration of GSH from GSSG [21].
Since the hepatotoxic effect of As is mainly due to the depletion of
GSH in the liver, hence, it may be hypothesized that taurine could
also play a protective role against As-induced hepatotoxicity.
The drinking water containing arsenic more than 10 mg/L is
harmful to the body. In human, signs of chronic toxicity appear
after long term exposure to a low dose of arsenic and thus we
selected comparatively higher dose of arsenic in the present study
using a rat model for achieving similar effects seen in humans.
Therefore, the chronic arsenic toxicity in rats was achieved by oral
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approximately 25 ppm in distilled water for 6 months [22]. The
present study has been undertaken to evaluate the beneficial role
of taurine in As-induced hepatic pathophysiology using both in
vivo and in vitro models by measuring in vivo antioxidant power,
levels of cellular metabolites (GSH, GSSG), activities of antiox-
Figure 1. Dose and time dependant effect of NaAsO2 and taurine. Panel A: Dose dependant effect of NaAsO2 on ALP level. Cont: ALP level in
normal rats; As-0.5, As-1, As-1.5, As-2, As-2.5, As-3: ALP level in NaAsO2 intoxicated rats at a dose of 0.5 mg, 1 mg, 1.5 mg, 2 mg, 2.5 mg and 3 mg/kg
body weight respectively for 6 months. Panel B: Dose and time dependent effect of taurine on ALP level against arsenic induced toxicity. Cont: ALP
level in normal rats, As: ALP level in NaAsO2 treated rats, TAU-10+As, TAU-20+As, TAU-30+As, TAU-40+As, TAU-50+As, TAU-60+As: ALP level in taurine
(TAU) treated rats for 2 weeks at a dose of 10, 20, 30, 40, 50 and 60 mg/kg body weight prior to NaAsO2 administration; TAU-0.5W+As, TAU-1W+As,
TAU-1.5W+As, TAU-2W+As, TAU-2.5W+As, TAU-3W+As: ALP level in taurine (TAU) treated rats for 0.5, 1, 1.5, 2, 2.5 and 3 weeks respectively at a dose
of 50 mg/kg body weight prior to As administration. Panel C: Time dependent effect of taurine on ALP level against NaAsO2 induced toxicity in
serum. Cont: ALP level in normal rats, As-0.5W, As-1W, As-2W, As-2.5W, As-3W: ALP level in NaAsO2 intoxicated rats after 0.5, 1, 2, 2.5 and 3 weeks
respectively from the last dose of NaAsO2,A s +TAU-0.5W, As+TAU-1W, As+TAU-1.5W, As+TAU-2.5W, As+TAU-3W: ALP level in taurine (TAU) treated
rats for 0.5, 1, 2, 2.5 and 3 weeks respectively at a dose of 50 mg/kg body weight after NaAsO2 administration. Each column represents mean 6 SD,
n=6. ‘‘a’’ indicates the significant difference between the normal control and As intoxicated groups and ‘‘b’’ indicates the significant difference
between taurine post-treated and recovery groups. (P
a,0.05, P
b,0.05).
doi:10.1371/journal.pone.0012602.g001
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mechanism underlying the protective action of taurine against
NaAsO2 induced hepatic dysfunction was assessed by evaluating
the role of different PKC isoforms and MAP kinase family
proteins. In addition, anti-apoptotic action of taurine was
evaluated by measuring the mitochondrial membrane potential,
intracellular ATP level, DNA fragmentation, alterations of the Bcl-
2 family proteins, Bim, cytosolic cytochrome C, activities of Apaf-
1, caspase 9, caspase 3, and PARP. The results of the present study
could clarify the role of this important bioactive molecule in the
prevention of As-induced hepatotoxicity, and may shed light on a
possible solution to the serious hepatic complications arising due to
As exposure.
Results
Dose dependent effect of NaAsO2 by ALP assay
In order to determine the dose-dependent As induced hepatic
damage, we carried out a dose-dependent study using ALP assay
as an index of that damage. As evidenced from figure 1A, in As
intoxicated animals, maximum ALP level in plasma was reached
at a dose of 2 mg/kg body weight after 6 months. Effect of As was
not much beyond this concentration. This dose was, therefore,
chosen as for As-induced hepatic damage throughout the study.
Dose and time dependent study of taurine by ALP assay
ALP assay was used to determine the optimum dose and time
necessary for taurine to protect rat liver against NaAsO2 induced
oxidative damages. Experimental results suggest that NaAsO2
intoxication (at a dose of 2 mg/kg body weight for, orally for 6
months) increased the ALP level and that could be prevented by
the pretreatment with taurine up to a dose of 50 mg/kg body
weight daily for 2 weeks (figure 1B).
Similarly post-treatment with taurine at a dose of 50 mg/kg
body weight daily for 2 weeks after NaAsO2 administration also
decreased the elevated level of ALP (figure 1C). These dose and
time were, therefore, chosen as the optimum dose and time for
taurine treatment throughout the study.
Effect of taurine on As-induced hepatotoxicity
To elucidate whether NaAsO2 administration induced liver
damage, we measured food intake, body weight, liver weight and
the serum specific marker enzymes activities. During the 6 months
of exposure of arsenic, no mortality occurred. There was no
significant difference in food and water intake between normal and
NaAsO2 exposed animals. Body weight and liver weight were
reduced in NaAsO2 exposed animals compared to control animals
although the liver weight to body weight ratios between these two
groups remained practically unaltered (table 1). Both Pre and post-
treatment with taurine significantly inhibited this alteration of the
liver and body weight.
We observed increased deposition of arsenic in the liver of
arsenic exposed animals, thus indicating the incapability of the
liver to eliminate the increased arsenic that the animals were
exposed to (table 1). Taurine effectively increased urinary arsenic
excretion and thus lowered the accumulation of arsenic in the liver
tissues (table 1). The status of the serum specific marker enzymes
related to liver dysfunctions has been represented in table 2.
NaAsO2 administration caused a significant increase in the
activities of ALT and ALP (table 1). However, taurine treatment
both pre and post to NaAsO2 administration reduced these levels
almost close to normal against NaAsO2 induced hepato-toxicity.
Table 1. Effect of taurine on NaAsO2- induced hepatotoxicity in experimental rats.
Parameters Normal Control Toxin Control TAU+As As+TAU TAU
Body weight(g) 265.2566.27 237.7265.16
a 259.7865.98
b 252.5965.77
b 267.5466.27
Liver weight(g) 5.7160.16 5.1260.13 5.4860.14 5.4060.14 5.7260.17
Ratio of the liver
Weight to the body weight (%)
2.1660.13 2.1560.13 2.1160.14 2.1460.14 2.1460.14
Hepatic Arsenic (mg/g tissue) 0.1660.01 1.5460.06
a 0.5260.03
b 0.6960.03
b 0.1360.01
Urinary Arsenic (mg/g creatinine) 7.8660.31 61.1362.57
a 118.4764.92
b 103.3764.09
b 10.5160.48
ALT (IU/L) 20.5460.06 38.5261.53
a 24.2461.12
b 26.7561.27
b 20.1560.08
ALP (KA Units) 27.5861.23 55.2663.21
a 32.3962.03
b 36.3862.05
b 25.4960.83
‘‘a’’ values differs significantly from normal control (P
a,0.05).
‘‘b’’ values differs significantly from toxin control (P
b,0.05).
Values are expressed as mean 6 SD, for 6 animals in each group.
doi:10.1371/journal.pone.0012602.t001
Table 2. Effect of taurine on NaAsO2-induced mitochondrial oxidative stress.
Parameters Normal Control Toxin Control TAU+As As+TAU TAU
GSH (nmol/mg protein) 8.3260.37 4.8260.27
a 7.8660.33
b 6.4160.28
b 9.1860.41
GSSG (nmol/mg protein) 0.1960.01 0.5460.03
a 0.2360.01
b 0.2860.01
b 0.1760.008
Redox ratio (GSH/GSSG) 43.7962.12 8.9260.52
a 34.1761.63
b 22.8961.11
b 54.062.31
MDA (nmol/mg protein) 3.7960.15 7.5360.34
a 4.6260.21
b 5.1460.22
b 3.1560.14
‘‘a’’ values differs significantly from normal control (P
a,0.05).
‘‘b’’ values differs significantly from toxin control (P
b,0.05).
Values are expressed as mean 6 SD, for 6 animals in each group.
doi:10.1371/journal.pone.0012602.t002
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taurine
GSH plays a critical role in scavenging ROS generated after the
toxic insult. A massive amount of GSH is consumed to accomplish
this task, thus shifting the redox status of the cell. Similar results
were exhibited in our study in which NaAsO2 drastically reduced
GSH/GSSG ratio by 4.9-fold (table 2) in liver mitochondria and
5.3-folds (table 3) in liver tissue confirming ROS generation and
oxidative stress. In addition we also found that peroxidation of
both mitochondrial (table 2) and total cellular lipid (table 3)
increased significantly in the liver following NaAsO2 administra-
tion. Treatment with taurine, however, maintained these levels
almost close to normal. Our results also indicated that adminis-
tration of taurine increases activities of antioxidant enzymes
(catalase, GST, GPx, GR, SOD and G6PD) compared to NaAsO2
exposed animals (table 4). Increase in the activities of these
enzymes prevents the mitochondrial generated reactive radicals
from causing oxidative stress, cellular damage and compensate for
lack of GSH functioning.
Effects of taurine against NaAsO2-induced H2O2 level
Arsenic-induced oxidative stress has been shown to cause DNA
damage through the production of superoxide and hydrogen
peroxide. Therefore, we measured the H2O2 level in hepatic
tissues of the experimental animals. We observed that hepatic
H2O2 level was significantly increased in NaAsO2 exposed animals
(table 4). However, treatment with taurine both pre and post to
NaAsO2 administration reduced this H2O2 production.
Taurine ameliorated As induced cytotoxicity
Our results showed that NaAsO2 caused loss in cell (hepato-
cytes) viability. To investigate whether this loss could be prevented
by taurine, we performed MTT assay. As evidenced from
figure 2A, reduction in cell viability increased with increasing
NaAsO2 concentration. Incubation of the hepatocytes with
NaAsO2 at a concentration of 10 mM for 8 hr showed optimum
reduction in cell viability. After that, the loss in cell viability
remains practically constant even with increasing NaAsO2
concentration. Therefore, this particular concentration of NaAsO2
has been used throughout the study. Figure 2B showed that the
increased taurine concentration (from 5 to 30 mM), caused a dose
dependent increase in viability of NaAsO2 treated cells. While
NaAsO2 exposed hepatocytes had a viability of only 62%, taurine
treatment increased the viability upto 93% when treated with
25 mM (optimum concentration) taurine. Therefore, this concen-
tration (25 mM) of taurine has been used in all the subsequent
studies.
Earlier experiments suggest that NaAsO2 induces reactive
oxygen species (ROS) generation in the liver tissue of experimental
animals [23]. So, we wanted to find out whether this toxin could
exert the same effect in the liver cells, hepatocytes and if it could,
whether taurine plays any protective role in this pathophysiology.
We, therefore, determined the ROS level in all sets of
experimental hepatocytes (normal, As-treated and taurine+As
treated). Fluorescence spectrometric analysis showed that NaAsO2
enhanced ROS generation in hepatocytes (Fig. 2C), (arrows
indicate fluorescent dye, DCF uptake by hepatocytes) and that
could be prevented by treatment with taurine.
Table 3. Effect of taurine on NaAsO2-induced oxidative stress in liver tissue.
Parameters Normal Control Toxin Control TAU+As As+TAU TAU
GSH (nmol/mg protein) 17.3660.826 8.5160.38
a 15.6960.71
b 13.1960.55
b 18.5860.82
GSSG (nmol/mg protein) 0.3460.02 0.8960.04
a 0.4160.02
b 0.4760.02
b 0.3160.01
Redox ratio (GSH/GSSG) 51.0662.23 9.5660.42
a 38.2761.85
b 28.0661.19
b 59.9462.29
MDA (nmol/mg protein) 3.2560.13 6.5160.31
a 4.0160.20
b 4.2460.19
b 3.0760.12
H2O2 (nmol/mg liver) 1.4660.06 3.1660.09
a 1.8360.08
b 1.9960.04
b 1.3260.07
‘‘a’’ values differs significantly from normal control (P
a,0.05).
‘‘b’’ values differs significantly from toxin control (P
b,0.05).
Values are expressed as mean 6 SD, for 6 animals in each group.
doi:10.1371/journal.pone.0012602.t003
Table 4. Effect of taurine and NaAsO2 on the activities of the antioxidant enzymes.
Name of the antioxidant enzymes Activities of the antioxidant enzymes
Normal Control Toxin Control TAU+As As+TAU TAU
SOD (Unit/mg protein) 116.4265.13 63.5763.02
a 106.9764.82
b 91.7664.21
b 121.1865.14
CAT (mmol/min/mg protein) 189.2268.63 89.7863.52
a 167.9667.52
b 159.7666.83
b 192.4868.71
GST (mmol/min/mgprotein) 3.5960.15 1.1660.05
a 2.3460.12
b 2.1260.10
b 3.6760.16
GR (nmol/min/mgprotein) 144.9166.82 66.3663.23
a 119.9465.21
b 109.4864.93
b 146.4266.83
GPx. (nmol/min/mgprotein) 157.0567.32 69.9163.21
a 144.5166.82
b 137.4166.57
b 159.4367.31
G6PD (nmol/min/mgprotein) 241.69610.29 132.5166.39
a 223.6269.68
b 217.0569.18
b 246.18610.30
‘‘b’’ values differs significantly from normal control (P
a,0.05).
‘‘b’’ values differs significantly from toxin control (P
b,0.05).
Values are expressed as mean 6 SD, for 6 animals in each group.
doi:10.1371/journal.pone.0012602.t004
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PLoS ONE | www.plosone.org 4 September 2010 | Volume 5 | Issue 9 | e12602Figure 2. Impact of As and taurine on cell viability, ROS production, Dym and intracellular ATP levels. Panel A: Dose dependent effect of
As on cell viability; Panel B: Dose dependent effect of taurine on As treated hepatocytes; Cont: cell viability in normal hepacytes; As-2.5, As-5, As-7.5,
As-10, As-12.5 and As-15: cell viability in As treated hepatocytes for 8 h at a dose of 2.5, 5, 7.5, 10, 12.5 and 15 mM; TAU-10, TAU-20, TAU-25, TAU-30,
and TAU-40: cell viability level in hepatocytes treated with taurine (1 h prior to As addition) and As for 8 h at a dose of 10, 20, 25, 30 and 40 mM.
Panel C: The intracellular ROS production was detected by DCF-DA method in As treated hepatocytes in absence (As) and presence of taurine
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PLoS ONE | www.plosone.org 5 September 2010 | Volume 5 | Issue 9 | e12602Mitochondrial membrane potential (Dym) was assessed in the
liver mitochondria of NaAsO2 exposed hepatocytes. Dym was
decreased in mitochondria isolated from the hepatocytes exposed
with As (Fig. 2D). Administration of taurine prevented this
NaAsO2-induced loss in Dym thereby indicating the membrane
stabilizing effect of taurine.
In addition, cellular ATP level was also measured and found
that this level was significantly lower in As-exposed hepatocytes
than in untreated ones (Fig. 2E). However, pretreatment of
hepatocytes with taurine could prevent this As-induced lowering of
ATP content.
Loss of the mitochondrial membrane potential promotes
cytochrome c release into cytosol and activates caspases via
apoptosome formation. Therefore, we assessed the leakage of
cytochrome c into cytosol and the status of caspases (initiator
caspase 9 and effector caspase 3) and Apaf-1 in NaAsO2
intoxicated hepatocytes. Immunoblot analyses showed an de-
creased mitochondrial cytochrome c level, increased cytosolic
cytochrome c and Apaf-1 level associated with up-regulation of
caspase 9, caspase 3 and cleaved caspase 3 in NaAsO2 exposed
hepatocytes indicating involvement of the mitochondrial apoptotic
pathway in this pathophysiology (figure 3A, 3B, 3C, 3D, 3E).
Taurine exerted its beneficial effect by inhibiting cytochrome c
release and Apaf-1. It was also found to be effective in inhibiting
caspase 3 and caspase 9 levels in the cytosol.
We then examined PARP cleavage to elucidate the molecular
mechanism underlying the protective effects of taurine against
NaAsO2-induced cell death as PARP cleavage represents a biochem-
ical hallmark of apoptosis. Western blot analysis revealed that NaAsO2
exposure caused the degradation of 116 kDa PARP to the
characteristic 84 kDa PARP fragment (figure 3F). However, taurine
treatment could inhibit this NaAsO2-induced cleavage of PARP.
As-induced apoptosis of hepatocytes: modulation by
taurine
We, further, investigated the mode of cell death in hepatocytes
isolated from NaAsO2-exposed rats using flow cytometric analysis,
DNA gel electrophoresis and DAPI staining. To characterize the
nature of NaAsO2-induced cell death pathway, we, first quantified
apoptotic cells among the injured ones using flow cytometry
analysis. As illustrated in Figure 4A, about 55.23% of the
hepatocytes isolated from NaAsO2-exposed rats underwent
apoptosis, among which 38.74% hepatocytes underwent early
apoptosis (annexin V
+/PI
2), 16.49% hepatocytes underwent late
apoptosis (annexin V
+/PI
+) and 11.20% hepatocytes underwent
necrosis (annexin V
2/PI
+). However both pre and post-treatment
with taurine (hepatocytes viability are respectively 81.89% and
74.48%) effectively reduced the numbers of both apoptotic and
necrotic cells indicating that taurine protected hepatocytes in
NaAsO2-induced hepatic pathophysiology.
Next, to show the apoptotic changes in the hepatocytes, we
examined the DNA fragmentation pattern. NaAsO2 caused a
DNA ladder fragmentation (a hallmark of apoptosis) associated
with a smear (figure 4B). Taurine treatment effectively reduced the
DNA laddering and smearing of the NaAsO2 exposed animals.
Finally we focused on the morphological changes of hepatocytes
undergoing apoptosis (induced by NaAsO2) using DAPI staining.
As shown in Figure 4C, hepatocytes from control animals exhibit
normal morphology, whereas cells from NaAsO2 exposed animals
were observed to have condensed and fragmented DNA in the
nucleus. Taurine treatment, however, restored the normal
morphology of these cells as evidenced from the figure 4C.
Taurine mitigated the pro-apoptotic effects of As on
Bcl-2 family and BH3-only proteins
Oxidative stress-induced apoptosis is directly related to
mitochondrial dysfunction. Therefore, we investigated whether
As-induced mitochondrial dysfunction is mediated by the Bcl-2
family proteins. We observed that NaAsO2 induced up-regulation
of pro apoptotic (active non-phospho form of Bad, Bax) and down-
regulation of anti apoptotic (active non-phospho form of Bcl-2,
Bcl-xL) Bcl-2 family proteins both in vivo and in vitro (Fig. 5A, 5B,
5C, 5D). However, taurine treatment inhibited As-induced up-
regulation of Bad, Bax and down-regulation of Bcl-2, Bcl-xL. To
further investigate whether arsenic exposure affects the expression
of Bcl-2 and Bax at the mRNA levels, transcription levels of Bcl-2
and Bax were checked in the liver tissue of the experimental rats.
Semi-quantitative analysis showed significant down regulation of
Bcl-2 gene and upregulation of Bax gene expressions following
arsenic exposure. However, these altered gene expressions were
reversed due to taurine treatment. Of the eight known BH3-only
proteins, only Bim and Bid bind and activate Bax. Since in the
present study, we set our aim to investigate mitochondrion
dependent apoptotic pathways and ‘‘Bid’’ is not involved in this
pathway, we investigated the effect of ‘‘arsenic and taurine’’ on
‘‘Bim’’ in hepatocytes apoptosis. Bim exists at the protein level as
three isoforms, including Bim extra long (BimEL), Bim long
(BimL), and Bim short (BimS). In the liver and hepatocytes,
BimEL was readily identified by immunoblot analysis. Arsenic
significantly increased cellular BimEL protein expression, whereas
treatment with taurine could reduce this alteration (Fig. 5E).
Activation of MAP kinase by NaAsO2, protection via
Taurine
To investigate whether MAPKs play any role in As-induced
hepatic pathophysiology and apoptotic cell death, we first
analyzed the activation status of ERK1/2, JNK, and p38 MAPK
by immunoblot analyses with antibodies specific to the phosphor-
ylated form of these kinases. NaAsO2 intoxication resulted in a
dramatic increase in the phosphorylated form of p38 and JNK
MAPKs in both rat liver and hepatocytes (Fig. 6). On the other
hand, the level of the phosphorylated ERK1/2 was not altered
significantly. However, taurine treatment both pre and post to
NaAsO2 administration significantly reduced all these As induced
alterations.
(TAU+As). SP600125+As: ROS production in hepatocytes treated with 10 mM SP600125 15 minutes before As exposure and incubated for 8 h,
SP600125+TAU+As: ROS production in hepatocytes treated with 10 mM SP600125 and 25 mM taurine 15 minutes before As exposure and incubated
for 8 h. Arrows indicate fluorescent dye, DCF uptake by hepatocytes. We have taken equal number of cells in each set as observed in microscope
under bright field. Panel D: mitochondrial membrane potential (Dym) was measured using a fluorescent cationic probe rhodamine-123 by flow
cytometer with FL-1 filter. Results represent one of the six independent experiments. Panel E: Effect of taurine on As-induced decrease in intracellular
ATP levels. CON, ATP levels in untreated hepatocytes; As: ATP levels in hepatocytes treated with As; TAU+As: ATP levels in hepatocytes treated with
taurine along with As. ‘‘a’’ indicates the significant difference between the normal control and toxin-treated cells, ‘‘b’’ indicates the significant
difference between toxin control and taurine-treated cells. Each column represents mean 6SD, n=6; (p
a,0.05, p
b,0.05).
doi:10.1371/journal.pone.0012602.g002
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PLoS ONE | www.plosone.org 7 September 2010 | Volume 5 | Issue 9 | e12602Figure 3. Immunoblot analysis on Mitochondrion-dependent pathway in absence (As) and presence of taurine (TAU+As). Panel A:
Mitochondrial cytochrome c, complex IV subunit was used as loading control. Panel B: Cytosolic cytochrome c, Panel C: Caspase 9, Panel D: Apaf 1,
Panel E: Caspase 3, Panel F: PARP. b actin was used as an internal control. Data represent the average 6 SD of 6 separate experiments in each group.
‘‘a’’ indicates the significant difference between the normal control and As treated groups, ‘‘b’’ indicates the significant difference between theA s
treated and taurine treated groups (TAU+As). (P
a,0.05, P
b,0.05).
doi:10.1371/journal.pone.0012602.g003
Figure 4. Mode of cell death in absence (As) and presence of taurine (TAU+As and As+TAU). Fig. A: percent distribution of apoptotic and
necrotic cells. Cell distribution was analysed using Annexin V binding (taken as x axis) and PI uptake (taken as y axis). The FITC and PI fluorescence
were measured using flow cytometer with FL-1 and FL-2 filters respectively. Results expressed as dot plot representing as one of the six independent
experiments. Fig. B: DNA fragmentation pattern on agarose/EtBr gel. DNA isolated from experimental liver tissues was loaded onto 1% (w/v) agarose
gels. Lane 1: Marker (1 kb DNA ladder); Lane 2: DNA isolated from normal liver; Lane 3: DNA isolated from As intoxicated liver; Lane 4: DNA isolated
from taurine pretreated liver samples, Lane 5: DNA isolated from taurine post-treated liver samples. Arrows indicate ladder formation in DNA isolated
from NaAsO2 intoxicated animals. Fig. C: DAPI staining. Cell nuclei of untreated or As and taurine treated hepatocytes were visualized following DNA
staining with the fluorescent dye DAPI and were observed using a microscope (original magnification 620). The measurements were made in six
times. Arrows indicate fragmented and condensed DNA in hepatocytes.
doi:10.1371/journal.pone.0012602.g004
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apoptosis
Based on the earlier result, we investigated whether p38 and
JNK MAPKs are involved in the prevention of As-induced
apoptosis in hepatocytes. The cells were pre-treated with
SB203580, SP600125 separately for 15 min for two different sets
of experiments and then effect of As on cell viability and caspase-3
activation were determined. Results showed that JNK inhibition
significantly increased cell viability and reduced caspase-3
activation in NaAsO2 exposed hepatocytes, where as p38
inhibition had no effect on these events (Fig. 7), indicating that
p38-MAPK is not involved in the prevention of As-induced
apoptosis. In presence of the JNK inhibitior, NaAsO2 did not
cause any significant change in ROS generation (Fig. 2C). When
cells were treated with taurine in presence of JNK inhibitor,
further reduction in ROS production (Fig. 2C) and caspase-3
inactivation were observed accompanied by an increase in cell
viability (Fig. 7), suggesting the involvement of JNK MAPK
signaling pathway in taurine mediated cyto protection.
Activation of PKC by NaAsO2, inhibition by taurine
The PKC family consists of a number of different serine/
threonine kinases, of which specific isoforms have been shown to
be either pro-apoptotic or anti-apoptotic, depending on the nature
of the stimuli and cell types used for the study [24,25,26,27]. We,
therefore, determined the role of major PKC isoforms in As
induced hepatic pathophysiology and observed that NaAsO2
intoxication significantly increased the expression of PKCd both in
vivo and in vitro, where as the expression of other two major
isoforms of PKC, (PKCa and PKCj) remained unchanged (Fig. 8).
Taurine treatment, however, significantly reduced this As induced
up-regulation of PKCd.
Effects of PKC d inhibition on As-induced apoptosis
To check whether there is any cross talk between PKC and
MAPKs, we pre-treated the hepatocytes with rottlerin for 30 min
and then studied the effects of As and taurine on JNK activation.
Rottlerin has been used as a PKCd inhibitor based on in vitro
studies that have shown that the IC50 for PKCd was 3–6 mM,
PKC a,b,c of 30–42 mM and PKC e,g,j of 80–100 mM [28].
Among the protein kinases tested, only CaM-kinaseIII is
suppressed by rottlerin as effectively as PKCd [28]. Recently it
has also been observed that rottlerin inhibits the Nuclear Factor
kB (NF-kB) [29]. However, in our present study, except PKCd no
other PKC isoforms has been activated. Besides, NFkB and CaM-
kinaseIII were also not involved in our study. Therefore, we used
rottlerin as a selective inhibitor for PKCd. We observed that
rottlerin reduced As-induced phosphorylation of PKCd and
significantly increased cell viability compared to As-induced
hepatocytes (Fig. 9). Results also showed that PKCd inhibitor
blocked the As-induced JNK activation with a similar trend to the
results of taurine treatment. Thus, these results suggest that taurine
Figure 5. Immunoblot analysis on Bcl-2 family and Bim in
response to As and taurine (TAU+As, As+TAU). Panel A: Bax,
Panel B: Bad, Panel C: Bcl-2, Panel D: Bcl-xL, Panel E: Bim-EL. b actin was
used as an internal control. Panel F: Tissue expression of mRNAs for Bax
and Bcl-2 in livers isolated from normal as well as NaAsO2 and taurine
treated rats. b actin was taken as an internal control. Data represent the
average 6 SD of 6 separate experiments in each group. ‘‘a’’ indicates
the significant difference between the normal control and As treated
groups, ‘‘b’’ indicates the significant difference between the As treated
and taurine treated groups. (P
a,0.05, P
b,0.05).
doi:10.1371/journal.pone.0012602.g005
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suppressing the activation of PKCd.
Histological assessment
Arsenic-induced liver injury and its protection by taurine in our
model are finally confirmed by the evidence of histological
changes. Histological assessments of different liver segments of the
normal and experimental animals have been presented in
figure 10. As induced prominent hepatocytes degeneration
indicated by arrows. Taurine treatment (both pre and post)
showed a considerable improvement in liver morphology.
Discussion
Literatures support the fact that arsenic has a direct toxic effect
on cellular respiration in liver mitochondria with an evidence of
oxidative stress and hepatic collagenesis in humans [30,31,32].
This toxic effect on cellular respiration occurs because arsenic
binds to lipoic acid in the mitochondria and inhibits pyruvate
dehydrogenase. The resulting uncoupling of mitochondrial
oxidative phosphorylation increases hydrogen peroxide produc-
tion, decreases cellular respiration and ultimately leads to
hepatotoxicity and porphyrinuria. The present study also showed
that exposure to sodium arsenite significantly increased ROS
production, enhanced oxidative stress and induced apoptosis in
hepatocytes. However, the liver conditions have been improved
upon taurine treatment.
The hepatotoxic effect of As is mainly due to the depletion of
GSH in the liver. In this present study, we observed several
indications of oxidative stress (such as depletion of GSH, increased
levels of GSSG and lipid peroxidation) in both hepatic tissues and
mitochondria. Mitochondrial GSH plays an important role in
maintaining mitochondria healthy and its depletion may cause
oxidative injury in hepatocytes. We also found a significant
increase in intracellular ROS production along with a fall in GSH
generating (G6PD and GR) and ROS scavenging (antioxidant)
enzymes (GST, GPx, SOD, CAT) activities in hepatic tissues.
However, taurine supplementation effectively reduced these
alterations in As induced hepatic pathophysiology. GSH has been
considered to be an important intracellular reductant for arsenic
methylation and transport [33,34], which in turn helps the
removal of arsenic from the body. Depletion of hepatic GSH
facilitates accumulation of arsenic in the liver and thus causes
oxidative stress. However taurine treatment significantly increased
hepatic GSH level and lowered the accumulation of arsenic in
hepatic tissues via increased urinary arsenic excretion. Therefore,
taurine-induced increased GSH level during exposure to toxic
electrophiles generated by arsenic as well as its rapid elimination/
excretion from the body play an important role in decreasing
oxidative stress.
Apoptosis, a phenomenon of programmed cell death, is a self-
destruction mechanism involved in a variety of biological events.
Mitochondria have been described as the garden of cell death and
play a crucial role in regulating cell death pathways [35,36]. ROS
are predominantly produced in mitochondria and play an
important role in apoptosis. The central executers of the apoptotic
pathways are Bcl-2 family proteins and caspases (cysteinyl aspartic
acid-specific proteases). Bcl-2 family members regulate apoptosis
by modulating the release of cytochrome c from mitochondria to
cytosol. In the cytosol, Apaf1, procaspase-9 and released
cytochrome c from the mitochondria interact to form the
apoptosome that drives the activation of caspase-3. To confirm
As-induced mitochondria-dependent apoptosis, we determined the
mitochondrial membrane potential, intracellular ATP level as well
as expressions of Bcl-2 family and BH-3 only proteins, cytochrome
c, caspase 3, caspase 9, Apaf1 and PARP in arsenic-induced
hepatic pathophysiology and observed that As significantly up-
regulated pro-apoptotic (Bad, Bax, Bim) and down-regulated anti-
apoptotic (Bcl-2, Bcl-xL) proteins, reduced mitochondrial mem-
brane potential and intracellular ATP level, increased cytochrome
c release and protein level of Apaf-1 in the cytosol. Reduction of
the mitochondrial membrane potential and activation of caspases
(caspase 3 and caspase 9) subsequently modulated PARP cleavage
from its full-length form (116 kDa) to the cleaved form (84 kDa).
In liver, arsenic also markedly enhances cellular Bax and reduces
Bcl-2 mRNA levels and therefore probably regulates Bax and Bcl-
2 expression by both transcriptional and post-transcriptional
levels. Taurine treatment, however, effectively inhibited all these
As-induced pro-apoptotic events.
MAPKs comprise a family of serine/threonine phosphorylating
proteins that mediate a variety of signal transduction pathways
[37,38]. Among the MAPKs, the c-Jun NH2-terminal kinases
(JNKs) and p38 result in stress responses, growth arrest, and/or
apoptosis. Therefore, in order to investigate the underlying
mechanisms of apoptosis in As intoxicated liver (and hepatocytes)
and the beneficial role of taurine in this hepatic pathophysiology,
we investigated the changes in the levels of ERK1/2, p38 and JNK
by immunoblot analyses. We observed a marked increase in
protein content of phosphorylated p38 MAPK and JNK in As-
intoxicated liver and hepatocytes. A marginal increment of pERKs
was also noted in both the liver and hepatocytes. We also observed
that, hepatocytes treated with JNK inhibitor SP600125, sup-
pressed the As-induced caspase 3 activation, cell viability reduction
and ROS production. However, a p38-MAPK specific inhibitor,
SB203580, had no effect on cell viability and caspase 3 activation
on hepatocytes exposed to As. The present study also showed that
taurine treatment prevented As-induced activation of Bim-EL in
liver and hepatocytes. Therefore, we can conclude that JNK may
induce hepatocyte apoptosis via a Bim-mediated, Bax-dependent
mitochondrial pathway of cell death. These observations are in
consistent with the data of other models where JNK-dependent
Bim induction as well as phosphorylation with downstream
activation of Bax-mediated apoptosis have been reported [39,40].
Protein kinase C (PKC) is a family of enzymes that are involved
in controlling the function of other proteins through the
phosphorylation of hydroxyl groups of serine and threonine
amino acid residues on those proteins. PKC family consists of at
least 12 members and can be classified into three groups based on
their biochemical properties and sequence homologies, e.g.
conventional PKC isoforms (cPKC-a,-bI,-bII,-c), novel PKC
isoforms (nPKC –d,–e,–m,–g,–h) and atypical PKC isoforms
(aPKC-l,–i,–j). The different PKC isoforms might have specific
roles in signal transduction. In our study, western blot analyses
revealed that NaAsO2 intoxication significantly increased the
expression of PKCd both in liver tissues and hepatocytes with out
changing the expression of other two major isoforms, PKCa and
Figure 6. Immunoblot analysis on MAPKinase family proteins in response to As and taurine (TAU+As and As+TAU). Panel A: Phospho
and total JNK, Panel B: Phospho and total p38, Panel C: Phospho and total ERK1/2. b actin was used as an internal control. Data represent the average
6 SD of 6 separate experiments in each group. ‘‘a’’ indicates the significant difference between the normal control and As treated groups, ‘‘b’’
indicates the significant difference between the As treated and taurine treated groups. (P
a,0.05, P
b,0.05).
doi:10.1371/journal.pone.0012602.g006
Taurine and As in Liver Damage
PLoS ONE | www.plosone.org 11 September 2010 | Volume 5 | Issue 9 | e12602Taurine and As in Liver Damage
PLoS ONE | www.plosone.org 12 September 2010 | Volume 5 | Issue 9 | e12602PKCj. However, treatment with taurine markedly suppressed this
As-induced phosphorylation of PKCd. Furthermore, the de-
creased JNK activity by the specific inhibitor of PKCd, rottlerin,
strongly suggests the involvement of PKCd in As-induced JNK
activation. Further studies will clarify the exact activation
mechanisms of PKCd in response to ROS. However, one possible
explanation is the production of intracellular H2O2 due to
NaAsO2 intoxication, which subsequently activates PKCd
[41,42]. As taurine treatment reduced the hepatic H2O2
production, As-induced PKCd activation was also suppressed.
As-induced liver injury in this model is also supported by the
histological changes and the increased arsenic content in the liver
tissue of the intoxicated animals. However, taurine could
effectively prevent the As-induced alterations of hepatic morphol-
ogy and increased the excretion of As from the liver tissues.
In summary, our study demonstrates a pivotal role of
mitochondria in hepatocytes apoptosis. Reactive oxygen species
generated during NaAsO2 exposure, induce PKCd activation,
which subsequently activates JNK and helps the progression of
apoptosis. Taurine treatment, on the other hand, attenuates As-
induced oxidative stress in the liver and thus prevents hepatic
apoptosis. This anti-apoptotic effect of taurine is mediated by
blocking the activation of PKCd and JNK, generation and
accumulation of ROS and elimination/excretion of As from the
body. Taken together, our findings outline a mechanistic under-
standing of how taurine protects liver from As-induced toxicity
(Fig. 11). In conclusion, present experimental findings point out the
importance of the chronology for the treatment outcome and
provided the protection that taurine could afford against arsenic-
induced hepatic dysfunction by its antioxidant potential as well as
other pathways involved in apoptotic cell death.
Materials and Methods
Chemicals
Taurine (2-aminoethane sulfonic acid), anti Caspase-3, anti
Cleaved Caspase-3, anti PARP, anti Apaf-1 antibodies were
purchased from Sigma-Aldrich Chemical Company (St. Louis,
USA). Anti BAD and anti Bcl-2 were purchased from Santa Cruz
Biotechnology (Santa Cruz, CA). Sodium arsenite (NaAsO2) was
bought from Sisco Research Laboratory (Mumbai, India).
Animals
Swiss albino adult male rats weighing approximately 200–250 g
and albino mice of Swiss strain, weighing between 20–25 g were
were purchased from M/S Gosh Enterprises, Kolkota, India.
Animals were acclimatized under laboratory condition for two
weeks prior to the experiments. All the experiments with animals
were carried out according to the approval and guidelines of the
Bose Institute animal ethical committee (the permit number is: 95/
99/CPCSEA).
Determination of dose for As induced hepatic
dysfunctions in vivo
To establish the dose of As necessary for hepatic damage, rats
were randomly allocated into seven groups each consisting of six
rats and they were treated as follows. First group served as normal
control (received only water as vehicle). Remaining six groups
were treated with six different doses of NaAsO2 orally (0.5 mg,
1 mg, 1.5 mg, 2 mg, 2.5 mg and 3 mg/kg body weight in distilled
water for 6 months).
Twenty-four hours after the final dose of NaAsO2 intoxication,
all rats were sacrificed and ALP levels were measured using serum
of all experimental rats.
Determination of dose and time dependent activity of
taurine by ALP assay
For this study, rats were randomly distributed into eight groups
each consisting of six animals. First two groups were served as
normal control (received only water as vehicle) and toxin control
(received 2 mg/kg body weight for 6 months, orally) respectively.
Remaining six groups of animals were treated with six different
doses of taurine (10mg, 20mg, 30mg, 40 mg, 50mg and 60mg/kg
body weight for 2 weeks, orally in distilled water) followed by
NaAsO2 intoxication (received 2 mg/kg body weight for 6
months, orally).
To determine the time dependent effects of taurine for pre-
treatment in NaAsO2-dependent hepatic disorder, rats were
divided into eight groups each consisting of six animals. First
two groups were served as normal control (received only water as
vehicle) and toxin control (received 2 mg/kg body weight for 6
months, orally) respectively. Other seven groups of animals were
treated with taurine orally at a dose of 50 mg/kg body weight,
once daily for 0.5,1, 1.5, 2, 2.5 and 3 weeks prior to NaAsO2
intoxication (received NaAsO2 at a dose 2 mg/kg body weight for
6 months, orally).
Similarly, to determine the time dependent effects of taurine for
post-treatment studies in NaAsO2-dependent hepatic disorder, rats
were divided into eight groups each consisting of six animals. First
three groups were served as normal control (received only water as
vehicle), toxin control (received 2 mg/kg body weight for 6
months, orally) and recovery (received 2 mg/kg body weight for 6
months, orally and received normal diet for next 2 weeks)
respectively. Other five groups of animals were treated with
taurine orally at a dose of 50 mg/kg body weight, once daily for
0.5, 1, 2, 2.5 and 3 weeks after NaAsO2 administration (received
2 mg/kg body weight for 6 months, orally).
At selected times after NaAsO2 and taurine treatment, all rats
were sacrificed. ALP levels were measured using serum of all
experimental rats.
In vivo experimental set-up
The animals were divided into five groups, consisted of six rats
in each and they were treated for 14 weeks as follows.
Group 1: ‘‘Normal control’’: animals received only water as
vehicle.
Group 2: ‘‘Toxin control (As)’’: animals received 2 mg/kg body
weight once daily for 6 months, orally.
Group 3: ‘‘Taurine pre-treated group (TAU+As)’’: animals were
treated with taurine (orally, 50 mg/kg body weight in distilled
water, once daily) for 2 weeks followed by NaAsO2 intoxication for
6 months.
Figure 7. Immunoblot analysis of caspase 3 and hepatocytes viability in response to SB203580 and SP600125. Hepatyocytes were pre-
treated with 10 mM SB203580 and SP600125 for 15 min, then treated with As (10 mM), taurine (25 mM, added 1 h prior to As treatment) for 8 h. Panel
A: effects of SP600125 on Caspase 3, Panel B: effects of SB203580 on Caspase 3, b actin was used as an internal control. Panel C: effects of SP600125
on cell viability, Panel D: effects of SB203580 on cell viability. Data represent the average 6 SD of 6 separate experiments in each group. ‘‘a’’ indicates
the significant difference between the normal control and As treated groups, ‘‘b’’ indicates the significant difference between the As treated and
taurine treated groups. (P
a,0.05, P
b,0.05).
doi:10.1371/journal.pone.0012602.g007
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NaAsO2 for 6 months followed by taurine administration at a dose
of 50 mg/kg body weight in distilled water once daily for 2 weeks.
Group 5: ‘‘Taurine alone treated group (TAU)’’: animals were
treated with taurine (orally, 50 mg/kg body weight in distilled water,
once daily) for 2 weeks followed by no treatment for next 6 months.
The animals were sacrificed under light ether anesthesia and
livers were collected.
Determination of liver weight to body weight ratio
After sacrification, the livers from experimental animals were
quickly excised and weighed. Then the ratio of liver weight to
body weight was measured for each.
Hepatic and urinary arsenic estimation
The arsenic contents in liver tissues and urinary assenic level of
all experimental animals were analyzed following the method of
Das et al [43] using hydride generation system in Atomic
Absorption Spectrophotometer (Perkin Elmer Model No. 3100).
Assessment of serum specific markers related to hepatic
dysfunction
For assessment of serum specific markers (ALT and ALP levels)
related to hepatic dysfunction, blood samples were collected by
puncturing rat hearts of all experimental animals, kept overnight
for clotting and then centrifuged at 3,000 g for 10 minutes. ALT
and ALP levels in the serum were measured by using standard kits
according to the method of Rietman and Frankel [44] and Kind
and King [45] respectively.
Preparation of liver homogenate
Liver samples were homogenized using glass homogenizer in
100 mM potassium phosphate buffer containing 1 mM EDTA,
pH 7.4 supplemented with protease and phosphatase inhibitors
and centrifuged at 12,000 g for 30 minutes at 4uC. The
supernatant was collected and used for the experiments.
Determination of protein content
The protein content of the experimental samples was measured
by the method of Bradford [46] using crystalline BSA as standard.
Assay of cellular metabolites
Reduced glutathione (GSH) level was measured following the
method of Ellman [47] by using DTNB (Ellman’s reagent) as the
key reagent. Oxidized glutathione GSSG contents in the hepatic
tissues of the experimental and normal animals were determined
following the method of Hissin and Hilf [48].
Measurement of lipid peroxidation
The lipid peroxidation in terms of malondialdehyde (MDA)
formation was measured according to the method of Esterbauer
and Cheeseman [49].
Estimation of hepatic H2O2 level
The hydrogen peroxide level in liver tissue was determined
using a slightly modified ferrous thiocyanate method of Chen et al
[50].
Assay of antioxidant enzymes
The activities of antioxidant enzymes, SOD, CAT, GST, GR,
GPx and G6PD have been measured in liver homogenates of all
experimental animals.
SOD activity has been measured by following the method
originally developed by Nishikimi et al [51] and then modified by
Kakkar et al [52].
CAT activity was determined by following the decomposition of
H2O2 at 240 nm for 10 minutes and it was monitored
spectrophotometrically according to the method of Bonaventura
et al [53].
GST activity was assayed based on the conjugation reaction
with glutathione in the first step of mercapturic acid synthesis
Habig et al [54].
GR activity was determined according to the method of Smith
et al [55]. The increase in absorbance at 412 nm was monitored
spectrophotometrically for 3 minutes at 24uC.
GPx activity was measured by following the method of Flohe
and Gunzler [56] using H2O2 and NADPH as substrates.
G6PD activity was determined as described by Lee [57].
Detection of cell death pathway by flowcytometry, DNA
fragmentation assay and DAPI staining
Hepatocytes were isolated from arsenic and taurine treated rat
liver by perfusion technique with collagenase type I at 37uC [58].
Cells were washed with PBS, centrifuged at 800 g for 6 min,
resuspended in ice-cold 70% ethanol/PBS, centrifuged at 800 g
for a further 6 min, and resuspended in PBS. Cells were then
incubated with propidium iodide (PI) and FITC-labelled Annexin
V for 30 min at 37uC. Excess PI and Annexin V were then washed
off; cells were fixed and then stained cells were analyzed by flow
cytometry using FACS Calibur (Becton Dickinson, Mountain
View, CA) equipped with 488 nm argon laser light source;
515 nm band pass filter for FITC-fluorescence and 623 nm band
pass filter for PI-fluorescence using CellQuest software.
The DNA fragmentation has also been assayed by electropho-
resing genomic DNA samples, isolated from normal as well as
experimental rat liver as above, on agarose/EtBr gel by the
procedure described by Sellins and Cohen [59].
To detect morphological evidence of apoptosis, cell nuclei were
visualized following DNA staining with the fluorescent dye DAPI
[60]. Hepatocytes isolated from NaAsO2 and taurine treated rats
as above were incubated for 10 min with DAPI (1 mg/ml) and
examined using fluorescent microscopy (Microphot FX; Nikon,
Tokyo).
Hepatocyte isolation and in vitro experimental protocol
Hepatocytes were isolated from rat liver following the method of
[58] with some modifications. Hepatocytes were then treated with
taurine (25mM), NaAsO2 (10 mM) and taurine coupled (1h before)
with NaAsO2 and incubated at 37uC for 8 hours for further
molecular and biochemical analyses.
Cell viability assessment
About 2610
6 hepatocytes were incubated with As either alone
or after taurine administration following the method of Madesh
and Balasubramanian [61]. The tetrazolium salt MTT can be
Figure 8. Immunoblot analysis of PKC family proteins in response to As and taurine (TAU+As and As+TAU). Panel A: Phospho and total
PKCa, Panel B: Phospho and total PKCd, Panel C: Phospho and total PKCj. Data represent the average 6 SD of 6 separate experiments in each group.
b actin was used as an internal control. ‘‘a’’ indicates the significant difference between the normal control and As treated groups, ‘‘b’’ indicates the
significant difference between the As treated and taurine treated groups. (P
a,0.05, P
b,0.05).
doi:10.1371/journal.pone.0012602.g008
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salts are reduced to formazan by mitochondrial succinate
dehydrogenase, an enzyme which is only active in cells with an
intact metabolism and respiratory chain. The formazan is
quantified photometrically and correlates with the number of
viable cells.
Measurement of intracellular ROS production
Briefly, hepatocytes were incubated with DCF-DA (10 mM) for
1 h at 37uC in the dark. After treatment, the cells were
immediately washed and resuspended in PBS. Intracellular ROS
production was detected using the fluorescent intensity of the
oxidant sensitive probe 2,7dichlorodihydrofluorescein diacetate
(H2DCFDA) in a fluorescence microscope.
Determination of mitochondrial membrane potential
(Dym)
After experimental treatment and following the method of
Hodarnau et al. [62], fresh mitochondria were isolated from
the liver tissue. Mitochondrial membrane potential (Dym)
was estimated [63] on the basis of cell retention of the
fluorescent cationic probe rhodamine 123. The results are
expressed as percentage of the fluorescence values for control
(untreated).
Intracellular ATP determination
Hepatocytes that were left untreated or treated with As alone or
pretreated with taurine were used for analysis of intracellular ATP
as described by Kalbheim and Koch [64].
Immunoblotting
For immunoblotting, samples containing 50 mg proteins were
subjected to 10% SDS-PAGE and transferred to a nitrocellulose
membrane. Membranes were blocked at room temperature for
2 h in blocking buffer containing 5% non-fat dry milk to prevent
non specific binding and then incubated with anti Bim-EL (1:1000
dilution), anti BAD (1:1000 dilution), anti Bcl-2 (1:1000 dilution),
anti cytochrome c (1:1000 dilution), anti cleaved caspase9 (1:1000
dilution), anti-cleaved caspase3 (1:250 dilution), Apaf-1(1:1000
dilution), anti-PARP (1:1000 dilution), anti p-38 (1:1000 dilution),
anti ERK1/2 (1:1000 dilution), anti p-JNK (1:1000 dilution),
PKCd (1:1000 dilution), PKCa (1:1000 dilution) and PKCj
(1:1000 dilution), primary antibodies at 4uC overnight. The
membranes were washed in TBST (50 mmol/L Tris-HCl,
pH 7.6, 150 mmol/L NaCl, 0.1% Tween 20) for 30 min and
incubated with appropriate HRP conjugated secondary antibody
(1:2000 dilution) for 2 h at room temperature and developed by
the HRP substrate 3,39-diaminobenzidine tetrahydrochloride
(DAB) system (Bangalore, India).
Figure 9. Immunoblot analysis of PKCd, JNK and cell viability in hepatocytes in response to rottlerin. Hepatyocytes were pre-treated
with 10 mM rottlerin for 30 min, then treated with As (10 mM), taurine (25 mM, added 1 h prior to As treatment) for 8 h. Panel A: effect of rottlerin on
Phospho and total PKCd, Panel B: effect of rottlerin on Phospho and total JNK, Panel C: effect of rottlerin on cell viability. b actin was used as an
internal control. Data represent the average 6 SD of 6 separate experiments in each group. ‘‘a’’ indicates the significant difference between the
normal control and As treated groups, ‘‘b’’ indicates the significant difference between the As treated and taurine treated groups. (P
a,0.05, P
b,0.05).
doi:10.1371/journal.pone.0012602.g009
Figure 10. Haematoxylin and eosin stained liver section of normal, arsenic and taurine-treated rats (610). Arrows indicate hepatocytes
degeneration around the central vain in NaAsO2 intoxicated animals.
doi:10.1371/journal.pone.0012602.g010
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RNA was extracted from liver that were left untreated or treated
with As alone or treated with taurine using the Trizol method.
One microgram of RNA was converted to cDNA using superscript
reverse transcriptase. Thermal cycling was performed as follows:
95uC for 105 s (initial denaturation) followed by the set of cycles:
95uC for15 s (denaturation), 55uC for 30 s (primer annealing),
72uC for 30 s (primer extension). After 25 cycles the time of DNA
extension was 7 min at 72uC. The PCR amplification products
were then cooled at 4uC. The PCR amplified products were then
subjected to electrophoresis on 1.5% agarose gels. The product
size and annealing temperature of the primers used were given in
table 5.
Histological studies
Livers from the normal and experimental rats were fixed in 10%
buffered formalin and were processed for paraffin sectioning.
Sections of about 5 mm thickness were stained with haematoxylin
and eosin to evaluate under light microscope.
Statistical Analysis
All the values are expressed as mean 6 S.D. (n=6). Significant
differences between the groups were determined with SPSS 10.0
software (SPSS Inc., Chicago, IL, USA) for Windows using one-
way analysis of variance (ANOVA) and the group means were
compared by Duncan’s Multiple Range Test (DMRT). A
difference was considered significant at the p,0.05 level.
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